{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T06:59:40Z","timestamp":1778914780205,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.anndiagpath.2019.06.006","type":"journal-article","created":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T09:04:55Z","timestamp":1560762295000},"page":"64-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The complementary role of insulin-like growth factor II mRNA-binding protein 3 (IMP3) in diagnosis of Hodgkin's lymphoma"],"prefix":"10.1016","volume":"42","author":[{"given":"Rokia","family":"Masoud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afaf.","family":"Ibrahiem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina","family":"Tantawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Eldosoky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.anndiagpath.2019.06.006_bb0005","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.mayocp.2015.07.005","article-title":"Hodgkin lymphoma: diagnosis and treatment","volume":"90","author":"Ansell","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.anndiagpath.2019.06.006_bb0010","series-title":"Cancer pathology registry, a 12-year registry 2000\u20132011","author":"Mokhtar","year":"2016"},{"issue":"1732","key":"10.1016\/j.anndiagpath.2019.06.006_bb0015","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1098\/rstb.2016.0271","article-title":"Epstein\u2013Barr virus-associated lymphomas","volume":"372","author":"Shannon-Lowe","year":"2017","journal-title":"Philos. Trans. R. Soc. B"},{"key":"10.1016\/j.anndiagpath.2019.06.006_bb0020","series-title":"Precision molecular pathology of Hodgkin lymphoma","year":"2018"},{"key":"10.1016\/j.anndiagpath.2019.06.006_bb0025","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues (revised 4th edition)","author":"Swerdlow","year":"2017"},{"key":"10.1016\/j.anndiagpath.2019.06.006_bb0030","article-title":"Rosai and Ackerman's surgical pathology E-book","author":"Goldblum","year":"2017","journal-title":"Elsevier Health Sciences"},{"issue":"4","key":"10.1016\/j.anndiagpath.2019.06.006_bb0035","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.prp.2016.02.006","article-title":"Expression of insulin-like growth factor \u0406I mRNA binding protein 3 (IMP3) in enchondroma and chondrosarcoma","volume":"212","author":"Shooshtarizadeh","year":"2016","journal-title":"Pathol Res Pract"},{"issue":"7","key":"10.1016\/j.anndiagpath.2019.06.006_bb0040","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.fertnstert.2013.02.002","article-title":"The oncofetal protein IMP3: a novel biomarker and triage tool for premalignant atypical endometriotic lesions","volume":"99","author":"Vercellini","year":"2013","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.anndiagpath.2019.06.006_bb0045","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.humpath.2010.06.003","article-title":"The use of insulin like-growth factor II messenger RNA binding protein\u20133 in diagnostic pathology","volume":"42","author":"Findeis-Hosey","year":"2011","journal-title":"Hum Pathol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2019.06.006_bb0050","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1309\/AJCP3FEPX5BEEKGX","article-title":"Differentiating between Burkitt lymphoma and CD10+ diffuse large B-cell lymphoma. The role of commonly used flow cytometry cell markers and the application of a multiparameter scoring system","volume":"137","author":"McGowan","year":"2012","journal-title":"Am J Clin Pathol"},{"issue":"10","key":"10.1016\/j.anndiagpath.2019.06.006_bb0055","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/j.humpath.2013.04.011","article-title":"IMP3 as a supplemental diagnostic marker for Hodgkin lymphoma","volume":"44","author":"Tang","year":"2013","journal-title":"Hum Pathol"},{"issue":"8","key":"10.1016\/j.anndiagpath.2019.06.006_bb0060","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.clml.2016.04.011","article-title":"Clinical implications of CD30 expression in aggressive B-cell lymphomas","volume":"16","author":"Malysz","year":"2016","journal-title":"Clinical Lymphoma, Myeloma and Leukemia"},{"key":"10.1016\/j.anndiagpath.2019.06.006_bb0065","series-title":"Atlas of differential diagnosis in neoplastic hematopathology","author":"Gorczyca","year":"2014"},{"issue":"105\u2013110","key":"10.1016\/j.anndiagpath.2019.06.006_bb0070","first-page":"15","article-title":"American registry of pathology expert opinions: immunohistochemical evaluation of classic Hodgkin lymphoma","volume":"39","author":"O'Malley","year":"2019","journal-title":"Ann Diagn Pathol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2019.06.006_bb0075","first-page":"637","article-title":"Hematopoietic neoplasms: controversies in diagnosis and classification, an issue of surgical pathology clinics","volume":"6","author":"George","year":"2013","journal-title":"Elsevier Health Sciences, E-Book"},{"issue":"5","key":"10.1016\/j.anndiagpath.2019.06.006_bb0080","doi-asserted-by":"crossref","first-page":"742","DOI":"10.5858\/2007-131-742-FEIDLB","article-title":"Fascin expression in diffuse large B-cell lymphoma, anaplastic large cell lymphoma, and classical Hodgkin lymphoma","volume":"131","author":"Bakshi","year":"2007","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"10.1016\/j.anndiagpath.2019.06.006_bb0085","first-page":"543","article-title":"Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?","volume":"150","author":"Pinkus","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/j.anndiagpath.2019.06.006_bb0090","series-title":"Diagnostic immunohistochemistry E-book: theranostic and genomic applications","author":"Dabbs","year":"2017"},{"issue":"11","key":"10.1016\/j.anndiagpath.2019.06.006_bb0095","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/01.MP.0000093627.51090.3F","article-title":"Expression of B-cell markers in classical Hodgkin lymphoma: a tissue microarray analysis of 330 cases","volume":"16","author":"Tzankov","year":"2003","journal-title":"Mod Pathol"},{"issue":"11","key":"10.1016\/j.anndiagpath.2019.06.006_bb0100","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.7150\/jca.13107","article-title":"CD20 over-expression in Hodgkin-Reed-Sternberg cells of classical Hodgkin lymphoma: the neglected quest","volume":"6","author":"Benharroch","year":"2015","journal-title":"J Cancer"},{"issue":"5","key":"10.1016\/j.anndiagpath.2019.06.006_bb0105","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1210\/er.2008-0028","article-title":"Unraveling insulin-like growth factor binding protein-3 actions in human disease","volume":"30","author":"Jogie-Brahim","year":"2009","journal-title":"Endocr Rev"},{"issue":"15","key":"10.1016\/j.anndiagpath.2019.06.006_bb0110","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1007\/s00018-012-1186-z","article-title":"Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?","volume":"70","author":"Bell","year":"2013","journal-title":"Cell Mol Life Sci"},{"issue":"7","key":"10.1016\/j.anndiagpath.2019.06.006_bb0115","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/sj.emboj.7601039","article-title":"RNA-binding IMPs promote cell adhesion and invadopodia formation","volume":"25","author":"Vikesaa","year":"2006","journal-title":"EMBO J"},{"issue":"8","key":"10.1016\/j.anndiagpath.2019.06.006_bb0120","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1515\/hsz-2013-0111","article-title":"Subcellular localization and RNP formation of IGF2BPs (IGF2 mRNA-binding proteins) is modulated by distinct RNA-binding domains","volume":"394","author":"W\u00e4chter","year":"2013","journal-title":"Biol Chem"},{"issue":"1","key":"10.1016\/j.anndiagpath.2019.06.006_bb0125","first-page":"3","article-title":"IMP3 overexpression occurs in various important cancer types and is linked to aggressive tumor features: a tissue microarray study on 8,877 human cancers and normal tissues","volume":"39","author":"Burdelski","year":"2018","journal-title":"Oncol Rep"},{"issue":"3","key":"10.1016\/j.anndiagpath.2019.06.006_bb0130","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/PAP.0000000000000021","article-title":"Oncofetal protein IMP3, a new cancer biomarker","volume":"21","author":"Gong","year":"2014","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.anndiagpath.2019.06.006_bb0135","doi-asserted-by":"crossref","DOI":"10.17795\/bhs27414","article-title":"The relationship between IMP3 expression in colorectal adenocarcinoma and clinicopathologic findings","author":"Radfar","year":"2015","journal-title":"J Biotechnol Health Sci"},{"issue":"12","key":"10.1016\/j.anndiagpath.2019.06.006_bb0140","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.humpath.2009.05.003","article-title":"IMP-3 is differentially expressed in normal and neoplastic lymphoid tissue","volume":"40","author":"King","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2019.06.006_bb0145","doi-asserted-by":"crossref","unstructured":"Zhang X, Tsang P, Danville. IMP3\/KOC1, a new immunohistochemical marker for differentiating classical Hodgkin lymphoma and nodular lymphocyte predominant Hodgkin lymphoma from diffuse large B-cell lymphoma. Am J Clin Pathol 2018;149: S64-S89.","DOI":"10.1093\/ajcp\/aqx121.195"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913419301613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913419301613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:31:35Z","timestamp":1761078695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913419301613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":29,"alternative-id":["S1092913419301613"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2019.06.006","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The complementary role of insulin-like growth factor II mRNA-binding protein 3 (IMP3) in diagnosis of Hodgkin's lymphoma","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2019.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}